Journal article
The association between radiographic response and overall survival in men with metastatic castration‐resistant prostate cancer receiving chemotherapy
Abstract
BACKGROUND: In men with metastatic castration-resistant prostate cancer (CRPC), the association of measurable tumor responses with overall survival (OS) is unknown. The authors retrospectively evaluated the TAX327 phase 3 trial to study this relation.
METHODS: Eligible patients for this analysis included those with World Health Organization (WHO)-defined measurable metastatic disease randomized to receive either docetaxel or mitoxantrone. OS …
Authors
Sonpavde; Pond GR; Berry WR; de Wit R; Eisenberger MA; Tannock IF; Armstrong AJ
Journal
Cancer, Vol. 117, No. 17, pp. 3963–3971
Publisher
Wiley
Publication Date
September 2011
DOI
10.1002/cncr.25982
ISSN
1097-0142